TG Therapeutics Inc (TGTX)

Exchange
NASDAQ
Symbol
TGTX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
Country
USA

Stock price

At close: October 31, 2025

  • Open
    34.01
  • High
    36.65
  • Low
    33.81
  • Close
    34.78
  • Volume
    3,259,740

Financial ratios

Dec 31, 2024